Paul WL - Search Results

1

Erythropoietin in renal transplant recipients: studies based on recombinant human erythropoietin radioimmunoassay.

Ward HJ, Sun CH, Paul WL, Koyle MA, Yanagawa N, Lee DB. Ward HJ, et al. Among authors: paul wl. Transplant Proc. 1989 Feb;21(1 Pt 2):2041-2. Transplant Proc. 1989. PMID: 2652668

2

Angiotensin-converting enzyme inhibition in the treatment of renal transplant erythrocytosis. Clinical experience and observation of mechanism.

Danovitch GM, Jamgotchian NJ, Eggena PH, Paul W, Barrett JD, Wilkinson A, Lee DB. Danovitch GM, et al. Transplantation. 1995 Jul 27;60(2):132-7. Transplantation. 1995. PMID: 7624954

3

Serum erythropoietin levels after renal transplantation.

Sun CH, Ward HJ, Paul WL, Koyle MA, Yanagawa N, Lee DB. Sun CH, et al. Among authors: paul wl. N Engl J Med. 1989 Jul 20;321(3):151-7. doi: 10.1056/NEJM198907203210304. N Engl J Med. 1989. PMID: 2664510

4

Integrating simulation models and statistical models using causal modelling principles to predict aquatic macroinvertebrate responses to climate change.

Le CTU, Paul WL, Gawne B, Suter P. Le CTU, et al. Among authors: paul wl. Water Res. 2023 Mar 1;231:119661. doi: 10.1016/j.watres.2023.119661. Epub 2023 Jan 24. Water Res. 2023. PMID: 36716568 Free article.

5

Insight into the multi-decadal effects of floods on aquatic macroinvertebrate community structure in the Murray River using distributed lag nonlinear models and counterfactual analysis.

Le CTU, Paul WL, Gawne B, Suter PJ. Le CTU, et al. Among authors: paul wl. Sci Total Environ. 2021 Feb 25;757:143988. doi: 10.1016/j.scitotenv.2020.143988. Epub 2020 Dec 2. Sci Total Environ. 2021. PMID: 33310576

6

Causal modelling applied to the risk assessment of a wastewater discharge.

Paul WL, Rokahr PA, Webb JM, Rees GN, Clune TS. Paul WL, et al. Environ Monit Assess. 2016 Mar;188(3):131. doi: 10.1007/s10661-015-5074-5. Epub 2016 Feb 1. Environ Monit Assess. 2016. PMID: 26832914

7

USP standards and activities affecting pharmacy practice.

Okeke CC, Barletta FP, Gray VA, Krasowski JA, Paul WL, Belson JJ, Grady LT. Okeke CC, et al. Among authors: paul wl. Am J Health Syst Pharm. 1997 Jul 15;54(14):1633-8. doi: 10.1093/ajhp/54.14.1633. Am J Health Syst Pharm. 1997. PMID: 9248610 No abstract available.

8

Time-resolved fluoroimmunoassay compared with radioimmunoassay of luteinizing hormone.

Ditkoff EC, Levin JH, Paul WL, Lobo RA. Ditkoff EC, et al. Among authors: paul wl. Fertil Steril. 1993 Feb;59(2):305-10. Fertil Steril. 1993. PMID: 8425623 Free article.

9

Lp(a) lipoprotein: relationship to cardiovascular disease risk factors, exercise, and estrogen.

Lobo RA, Notelovitz M, Bernstein L, Khan FY, Ross RK, Paul WL. Lobo RA, et al. Among authors: paul wl. Am J Obstet Gynecol. 1992 Apr;166(4):1182-8; discussion 1188-90. Am J Obstet Gynecol. 1992. PMID: 1533091

10

The gonadotropin-releasing hormone antagonist (Nal-Glu) acutely blocks the luteinizing hormone surge but allows for resumption of folliculogenesis in normal women.

Ditkoff EC, Cassidenti DL, Paulson RJ, Sauer MV, Paul WL, Rivier J, Yen SS, Lobo RA. Ditkoff EC, et al. Among authors: paul wl. Am J Obstet Gynecol. 1991 Dec;165(6 Pt 1):1811-7. doi: 10.1016/0002-9378(91)90037-r. Am J Obstet Gynecol. 1991. PMID: 1750480 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters